A SYSTEM FOR DETERMINING INDIVIDUAL FFR VALUES FOR THE LESIONS OF A MULTI-LESIONED BLOOD VESSEL, MULTI- LESION FFR PROCESSOR THEREFOR, AND METHOD
THEREFOR
Field of the Invention
The invention relates to determining the values of intravascular hemodynamic parameters in general, and the individual Fractional Flow Reserve (FFR) values for the lesions of a multi-lesioned blood vessel in particular.
Background of the Invention
Vascular diseases are often manifested by reduced blood flow due to atherosclerotic occlusion of blood vessels due to the isolated lesion of a single- lesioned blood vessel or the multiple typically either two or three lesions of a multi-lesioned blood vessel. For single-lesioned blood vessels, clinical studies have shown that angioplasty may be avoided in most cases in which Fractional Flow Reserve (FFR) >0.75, and conversely should be considered for cases in which FFR<0.75 as described in "Pressure-based simultaneous CFR and FFR measurements: understanding the physiology of a stenosed vessel", Shalman, E. et al., Comput. Biol. and Med. 31 (2001) 353-363.
However, it has been found that the technique for deteπnining the FFR value for the isolated lesion of a single-lesioned blood vessel is not applicable for determining the individual FFR value of a lesion of a multi-lesioned blood vessel due to hemodynamic interaction between its lesions as described in "Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery. Validation in humans.'" by Pijls NJH, et al., Circulation, 2000; 102:2371 :2377, and "Pressure derived fractional flow reserve to assess serial epicardial stenoses: theoretical model and animal validation.'" by De Bruyne B, et al., Circulation, 2000; 101:1840:1847. To overcome this
problem, the articles describe a technique requiring complete obstruction of a tandem-lesioned blood vessel with two lesions for obtaining a so-called wedge pressure denoted Pw for determining the individual FFR values of the two lesions, thereby limiting the analysis to after at least partial treatment of the lesioned blood vessel.
Summary of the Invention
Generally speaking, the present invention enables the determination of the individual FFR values for the lesions of a multi-lesioned blood vessel during the diagnostic stage prior to intervention by virtue of the determination being based on pressure measurements acquired during continuous blood flow therethrough. The pressure measurements include an aortic pressure measurement acquired proximal to the first lesion of a multi-lesioned blood vessel, pressure measurements proximal and distal to the kth lesion of interest, and at least a hyperemic pressure measurement distal to the last lesion of the lesioned blood vessel. The pressure measurements proximal and distal to the k11 lesion of interest, and distal to the last lesion of a multi-lesioned blood vessel can be acquired with a pressure transducer of a pressure guide wire being deployed stationary at different positions therealong or alternatively they can be obtained during a so-called "pullback" procedure as described in "Practice and Potential Pitfalls of Coronary Pressure Measurement", Pijs, N. H. J., et al., Catherterization and Cardiovascular Interventions 49:1-16 (2000).
Determining the individual FFR values of the lesions of a multi-lesioned blood vessel is preferably achieved by means of an intermediate parameter termed the partial FFR value (hereinafter denoted "pFFRk") for the first k lesions of a multi-lesioned blood vessel defined as the ratio of the maximal hyperemic pressure Pk distal to the klh lesion divided by the maximal hyperemic aortic pressure P0, namely, pFFRIc = Pi/Po, whereupon the desired individual FFRk value of a kth lesion of a multi-lesioned blood vessel is calculated from the following FFR relationship developed hereinbelow:
' -FFRk α.PFFRk-ι -PFFR
FFR^ pFFR2
where pFFRk is its partial FFR value, and pFFRk-] and pFFRn are respectively the partial FFR values of the k-llh and the last lesions of the multi-lesioned blood vessel. The hyperemic aortic pressure P0 can be equally and is preferably acquired at rest since aortic pressure is substantially equal both at rest and during hyperemia.
It is well known that the pressure gradient Δp across a klh lesion of a multi-lesioned blood vessel is proportional to the square of the flow therethrough: Δρk= pk-ι - ρk = αk Q2 Eqn. (1) where the constant αk is a function of its geometry, and Q is the flow through the blood vessel as discussed in articles: "Simultaneous assessment of coronary flow reserve and fractional flow reserve with a novel pressure-based method", Graberg, L., et al., Journal of Interventional Cardiology, 2000; 13:323-329, and the aforementioned "Pressure-based simultaneous CFR and FFR measurements: understanding the physiology) of a stenosed vessel", Shalman, E., et al., Comput. Biol. Med. 31 (2001) 353-364.
Substituting Q = Qmax pFFRn into Δpk = Pk-] - Pk = αk Q2, the following equation for the kth lesion of a multi-lesioned blood vessel is obtained: ΔPk = Pk_r Pk = αk Qmax 2 pFFRn 2
Dividing this equation by the hyperemic aortic pressure P
0, substituting pFFR
k-] for P
k-]/Po and pFFR
k for P
k/P
0, and dividing both sides by the term pFFR„
2 renders the following equation: ρFFR
k_, -pFFR
k = α
k Q
1ιax pFFRj P
0 For the case of a single lesioned blood vessel, k=n=l such that pFFR
k-ι=P
0/Po=l, and pFFR
k= pFFR
n=FFR
k which on substitution into Eqn. (1) leads to
Equating the left hand sides of the Eqns. (2) and (3), leads to the following FFR quadratic equation for determining the individual FFR value for a klh lesion of a multi-lesioned blood vessel: l -FFRk = p iFTrFπRt? k_, _- 1p-ιTFττFrτR?
Eqn. (4) FFRk pFVRl
Eqn. (4) requires at least two hyperemic pressure measurements for determining the individual FFR value for a k
th lesion of a multi-lesioned blood vessel depending on its location i.e. k=l, 2, .., n, and the number of lesions n. Since obtaining hyperemic pressure measurements is complicated and time consuming, an alternative approach for solving the FFR quadratic equation is preferable dependent on finding a suitable term to replace the righthand nominator, namely, ρFFR
k-rpFFR
k. From Eqn. (1),
Q
rest 2 such that on re-arranging terms ΔP
k= Δp
k (Po-P
n)/(Po-p
n) where capital case P and small case p respectively denote hyperemic pressure measurements, and pressure measurements at rest. Also, since Δp
k=p
k- p , and pFFR
k- pFFR
k = P
k-]/Po - P
k/P
0 = ΔP
k/ P
0, then
PFFR
k-rpFFR
k = ΔP
k/ P
0 where ΔP
k= (p
k_,-p
k) (P
0-P„)/(p
0- P. -
Brief Description of the Drawings
In order to understand the invention and to see how it can be carried out in practice, preferred embodiments will now be described, by way of non-limiting examples only, with reference to the accompanying drawings, in which similar parts are likewise numbered, and in which:
Fig. 1 is a block diagram of a system for determining the individual FFR values for the lesions of a multi-lesioned blood vessel; Fig. 2 is a graph showing exemplary pressure waveforms of distal pressure measurements simultaneously acquired by a fluid filled pressure transducer and a pressure guide wire;
Fig. 3 is a flow diagram showing the steps of a method for determining the individual FFR value for a klb lesion of a multi-lesioned blood vessel;
Fig. 4 is a graph showing a mean pressure pulse acquired distal to a lesion at rest before synchronization; Fig. 5 is a graph showing the pressure pulse of Figure 4 after synchronization;
Fig. 6 is a graph comparing the individual FFR values for the lesions of tandem-lesioned blood vessels in nine human patients obtained using the single vasodilatation induction approach of the present invention with the individual FFR values obtained for the same nine patients using the aforementioned Pijls &
DeBrayne technique; and
Fig. 7 is a graph comparing the individual FFR values for the lesions of the tandem-lesioned blood vessels in nine human patients obtained using the multi-vasodilatation induction approach of the present invention and the individual FFR values obtained for the same nine patients using the aforementioned Pijls & DeBruyne technique.
Detailed Description of the Preferred Embodiments
Figure 1 shows a system 1 for detemiining the individual FFR values for the lesions 2 A, ... , 2K- 1 , 2K, 2K+ 1 , ...., and 2N of a multi-lesioned blood vessel 3 for enabling the determination of the necessity of medical treatment of each lesion, and the type. The system 1 is under the control of a user console 4 including a display 6, and includes intravascular pressure measurement apparatus 7 for acquiring pressure waveforms both proximal to the lesions, and distal thereto. The system 1 further includes a multi-lesion FFR processor 8 programmed for calculating the individual FFR values for each kth lesion where k=l, 2, ..., n. In a preferred embodiment of the present invention, the user console 4, the display 6 and the multi-lesion FFR processor 8 are embodied as a general puipose digital computer.
The intravascular pressure measurement apparatus 7 includes a guiding catheter 9 connected to a fluid filled pressure transducer 11 for acquiring pressure measurements outside of patient's body at position A for use as a reference signal. An exemplary guiding catheter 9 is the Ascent JL4 catheter commercially available from Medtronic, USA whilst an exemplary fluid filled pressure transducer 11 is commercially available from Biometrix, Jerusalem, Israel. The intravascular pressure measurement apparatus 7 also includes a pressure guide wire 12 with a pressure transducer 13 at its tip connected to a signal conditioning device 14 for acquiring hyperemic and non hyperemic pressure measurements along the blood vessel proximal and distal to the lesions 2. An exemplary pressure guide wire 12 is the PressureWire™ pressure guide wire commercially available from Radi Medical Systems, Uppsala, Sweden whilst an exemplary signal conditioning device 14 is also commercially available from Radi Medical Systems. With reference to Figures 2-5, the use of the system 1 for determining the
FFR value for a klh lesion of a multi-lesioned blood vessel is now described in connection with the single vasodilatation induction approach using the same notation as before, namely, capital case P denotes hyperemic pressure measurements and small case p denotes pressure measurements at rest: The guiding catheter 9 is introduced into the multi-lesioned blood vessel 3 to location A proximal to the lesion 2 A. The pressure guide wire 12 is introduced into the guiding catheter 9 such that its pressure transducer 13 is also proximal to the lesion 2A. The fluid filled pressure transducer 11 continuously acquires the aortic pressure for use as a baseline for correcting pressure measurements acquired by the pressure transducer 13 to compensate for various factors, for example, breathing, patient movement, and the like, which may influence the pressure measurements since they are not acquired simultaneously. The pressure guide wire 12 is advanced to positions proximal to the intermediate lesions, 2K- 1, 2K, and 2K+1, and distal to the lesion 2N for acquiring pressure measurements thereat. Figure 2 illustrates pressure measurements simultaneously acquired by
the fluid filled pressure transducer 11 and the pressure transducer 13. The pressure measurement distal to the last lesion 2N is repeated after induction of vasodilatation by administration of a suitable vasodilatation medicament, for example, adenosin. Upon acquiring the pressure measurements, the multi-lesion FFR processor 8 executes the following steps to determine the individual FFR value for a klh lesion of interest:
Step 1 : Calculate four amplification factors A -], Ak) An(rest), and n(hyperemic) from the pressure measurement acquired by the pressure transducer 11 for nomialization purposes. The subscripts of the amplification factors correspond to the location of the pressure transducer 13 along the blood vessel, namely, proximal and distal to the ktb lesion of interest, and distal to the last lesion at rest and at hyperemia. Each amplification factor is the ratio between the mean pressure measurement corresponding to the location of the pressure transducer 13 with respect to the aortic mean pressure.
Step 2: Separate the pressure measurement acquired by the pressure transducer 13 into four sets of discrete pulses, namely, each starting and ending with a local minimum, respectively proximal and distal to the kth lesion of interest, and distal to the last lesion at rest and at hyperemia. Step 3: Amplify the discrete pulses using the factors Ak-1, Ak, An(rest), and n(hyperemic)j respectively, and synchronize them such that each pulse has the same period between its local minimum values using a technique known as Automatic Synchronization Transformation (AST). Figures 4 and 5 illustrate the same pressure pulse before and after synchronization, respectively. Step 4: Calculate four series of mean pressure measurements pk-ι, pk, pn and P„ from the synchronized amplified pulses.
Step 5: Calculate values of pFFRk-1-pFFRk where pFFRk- pFFRk=ΔPk/P0 and ΔPk=(pk-rpk) (Po-Pn)/(po-Pn) on the assumption that Po^o, and pFFRn values where pFFRn=P„/Po also on the assumption that Po=po-
Step 6: Calculate the FFR value for the kth lesion of interest by solving the FFR quadratic equation: l - FFRk = pFFRk_, - pFFRk FFRk ~ pFFR* using the third largest values for each of pFFRk-rpFFR ι and pFFRn from Step 6. Figure 6 shows that the individual FFR values obtained using the above approach have a high correlation of about 0.92 with those obtained using the Pijls & DeBrayne technique for the same nine human patients.
The system 1 may alternatively be employed for determining the individual FFR values for the lesions of a multi-lesioned blood vessel by solving the FFR quadratic equation using multiple hyperemic pressure measurements. In this case, vasodilatation is repeatedly induced prior to pressure measurements taken proximal and distal to a klh lesion of interest, and distal to the last lesion. The pressure measurements using the fluid filled pressure transducer 11 are also taken to use for baseline purposes as described hereinabove. Figure 7 shows that the individual FFR values obtained using the multiple vasodilatation induction approach of the present invention also have a high con-elation of about 0.9 with those obtained using the Pijls & DeBrayne technique for the same nine human patients.
While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications, and other applications of the invention can be made within the scope of the appended claims. For example, pressure data may be mean pressures over a heartbeat, maximal diastolic pressures, and the like.